Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
Balanced Pharma develops pharmaceutical and medical device products for dental and dermatological applications. The company is led by experienced executives and clinicians with backgrounds in pharmaceutical manufacturing, dentistry, and medical device innovation.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Bay Point Laboratories is a California-based analytical lab that tests cannabis products—including flowers, edibles, oils, and medical products—for potency, cannabinoid levels, contamination, and consistency. It serves cannabis growers, distributors, and buyers, offering sampling services, on-demand testing packages, and consultations on soil and water contamination sources.
0 investors
0 investors
Beaconcure offers Verify, an AI-enabled platform for validating and reviewing statistical analysis outputs (TLFs from ADaM data) in clinical trials. It serves biometrics and statistical teams at pharmaceutical companies to speed data validation, quality control, and regulatory submission readiness.
0 investors
Bectas Therapeutics is a biotech company operating in the therapeutic development space. The page features CEO Ronan O'Hagan discussing biotech industry insights, leadership, team building, and organizational culture.
0 investors
NuStat markets an over-the-counter bleeding-control product that the page states meets or exceeds U.S. Department of Defense specifications for quality and functionality. The product is positioned in the medical/hemostatic wound-care category.
0 investors
Belhaven Bio develops a temperature-stable, needle-free delivery device for epinephrine and other emergency medications, designed to be more compact, affordable, and longer-lasting than traditional liquid injectables for patients with severe allergies and anaphylaxis conditions.
0 investors
0 investors
0 investors
0 investors
Benitec Biopharma is a clinical-stage biotechnology company developing genetic medicines using its ddRNAi platform, which combines RNA interference with gene therapy to silence disease-causing genes through a single administration. It develops therapeutics for chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD).
0 investors
0 investors